Skip to main content

After a Rough October, Leveraged Biotech ETF Looks to Bounce Back

Biotechnology stocks and exchange traded funds participated in the October broader market swoon, punishing funds such as the Direxion Daily S&P Biotech Bull Shares (NYSEArca: LABU) in the process. LABU, which takes the 3x or 300% daily performance of the S&P Biotechnology Select Industry...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.